Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum ...
Iterum Therapeutics (NASDAQ:ITRM) stock shot up 54% Friday after the company received FDA approval for its drug Orlynvah for ...
SHANGHAI, Oct. 25, 2024 /PRNewswire/ — Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of Phase I clinical trial of MRX-5 in Australia, a ...